When we applied the same cutoff point to the MDS validation cohort, the prognostic significance of HOXB-AS3 expression for OS in MDS patients was also confirmed (Fig. 5c and Additional file 1: Figure S15b). Here, PDS5B is linked to myelodysplastic syndrome.